These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36902471)

  • 1. Effects of Terahertz Radiation on the Aggregation of Alzheimer's Aβ42 Peptide.
    Wang L; Cheng Y; Wang W; Zhao J; Wang Y; Zhang X; Wang M; Shan T; He M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Terahertz Waves on the Structure of the Aβ42 Monomer, Dimer, and Protofibril: Insights from Molecular Dynamics Simulations.
    Chen C; Yan ZS; Ma YQ; Ding HM
    ACS Chem Neurosci; 2023 Dec; 14(23):4128-4138. PubMed ID: 37983764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer's disease.
    Ghosh P; Kumar A; Datta B; Rangachari V
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S24. PubMed ID: 20946608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new pentapeptides as potential inhibitors of amyloid-β
    Kaur A; Goyal B
    J Mol Graph Model; 2023 Nov; 124():108558. PubMed ID: 37390790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Alzheimer's amyloid-β
    Narang SS; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Apr; 38(6):1598-1611. PubMed ID: 31046642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
    Singh K; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of K16A and K28A mutation on the structure and dynamics of amyloid-β
    Shuaib S; Saini RK; Goyal D; Goyal B
    J Biomol Struct Dyn; 2020 Feb; 38(3):708-721. PubMed ID: 30821624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution NMR studies of Aβ monomer dynamics.
    Wang C
    Protein Pept Lett; 2011 Apr; 18(4):354-61. PubMed ID: 21222639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxicity and physicochemical properties of Abeta mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimer's disease.
    Murakami K; Irie K; Morimoto A; Ohigashi H; Shindo M; Nagao M; Shimizu T; Shirasawa T
    J Biol Chem; 2003 Nov; 278(46):46179-87. PubMed ID: 12944403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ
    Saini RK; Shuaib S; Goyal D; Goyal B
    J Biomol Struct Dyn; 2019 Aug; 37(12):3183-3197. PubMed ID: 30582723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A plant cell-based system that predicts aβ42 misfolding: potential as a drug discovery tool for Alzheimer's disease.
    Zhao T; Zeng Y; Kermode AR
    Mol Genet Metab; 2012 Nov; 107(3):571-9. PubMed ID: 22944366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the Mode of Action of the Clinical Stage All-d-Enantiomeric Peptide RD2 on Aβ42 Aggregation.
    Zhang T; Gering I; Kutzsche J; Nagel-Steger L; Willbold D
    ACS Chem Neurosci; 2019 Dec; 10(12):4800-4809. PubMed ID: 31710458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Ovocystatin on Amyloid β 1-42 Aggregation-In Vitro Studies.
    Stańczykiewicz B; Goszczyński TM; Migdał P; Piksa M; Pawlik K; Gburek J; Gołąb K; Konopska B; Zabłocka A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of 12-Crown-4 with Alzheimer's Aβ40 and Aβ42 Monomers and Its Effect on Their Conformation: Insight from Molecular Dynamics Simulations.
    Agrawal N; Skelton AA
    Mol Pharm; 2018 Jan; 15(1):289-299. PubMed ID: 29200307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Characteristics of Monomeric Aβ42 on Fibril in the Early Stage of Secondary Nucleation Process.
    Noda K; Tachi Y; Okamoto Y
    ACS Chem Neurosci; 2020 Oct; 11(19):2989-2998. PubMed ID: 32794732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structures of the E22Δ mutant-type amyloid-β alloforms and the impact of E22Δ mutation on the structures of the wild-type amyloid-β alloforms.
    Coskuner O; Wise-Scira O; Perry G; Kitahara T
    ACS Chem Neurosci; 2013 Feb; 4(2):310-20. PubMed ID: 23421682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.